Showing results (581-590 of 795) with videos related to

Sort By:
Pageof 80
The Science of the Total Environment|October 12, 2024
Exposure effects of synthetic glucocorticoid drugs on skeletal developmental and immune cell function in zebrafishCharles M Hamilton, Matthew J Winter, Jonathan S Ball, et al.
AJR. American Journal of Roentgenology|August 1, 1986
Multiple-angle, variable-interval, nonorthogonal MRIM A Reicher, R B Lufkin, S Smith, et al.
Bone Marrow Transplantation|November 20, 2002
Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recoveryM Y Ali, Y Oyama, J Monreal, et al.
Clinical Oral Investigations|May 8, 2014
Effect of growth factors on antimicrobial peptides and pro-inflammatory mediators during wound healingH Dommisch, J Winter, W Götz, et al.
Bone Marrow Transplantation|January 27, 2004
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?A Verma, J Pedicano, S Trifilio, et al.
American Journal of Respiratory Cell and Molecular Biology|November 1, 1993
Early changes in the calcitonin gene-related peptide (CGRP) content of pulmonary endocrine cells concomitant with vascular remodeling in the hypoxic ratM Roncalli, D R Springall, M Maggioni, et al.
Bone Marrow Transplantation|June 26, 2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazoleS Trifilio, S Singhal, S Williams, et al.
Clinical Endocrinology|June 4, 2016
Patients with high-risk differentiated thyroid cancer have a lower I-131 ablation success rate than low-risk ones in spite of a high ablation activityJ Winter, M Winter, T Krohn, et al.
Drug and Alcohol Dependence|June 25, 2015
Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, AustraliaR J Winter, M Stoové, L Degenhardt, et al.
British Journal of Cancer|November 1, 1988
Prednisolone improves the response to primary endocrine treatment for advanced breast cancerR D Rubens, C L Tinson, R E Coleman, et al.
Pageof 80